Cargando…

Harnessing NKT cells for vaccination

Natural killer T (NKT) cells are innate-like T cells capable of enhancing both innate and adaptive immune responses. When NKT cells are stimulated in close temporal association with co-administered antigens, strong antigen-specific immune responses can be induced, prompting the study of NKT cell ago...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burn, Olivia K, Pankhurst, Theresa E, Painter, Gavin F, Connor, Lisa M, Hermans, Ian F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9914585/ https://www.ncbi.nlm.nih.gov/pubmed/36845569 http://dx.doi.org/10.1093/oxfimm/iqab013

Ejemplares similares

Intratumoural administration of an NKT cell agonist with CpG promotes NKT cell infiltration associated with an enhanced antitumour response and abscopal effect
por: Prasit, Kef K, et al.
Publicado: (2022)

Harnessing Invariant NKT Cells to Improve Influenza Vaccines: A Pig Perspective
por: Yang, Guan, et al.
Publicado: (2017)

Exploiting invariant NKT cells to promote T-cell responses to cancer vaccines
por: Hunn, Martin K., et al.
Publicado: (2013)

NKT cell-dependent glycolipid–peptide vaccines with potent anti-tumour activity
por: Anderson, Regan J., et al.
Publicado: (2015)

22511 Glycolipid-loaded nanoparticles harness iNKT cells for tumor immunotherapy
por: Shute, Travis, et al.
Publicado: (2021)

Modulating the Tumour Microenvironment by Intratumoural Injection of Pattern Recognition Receptor Agonists
por: Burn, Olivia K., et al.
Publicado: (2020)

Exploiting the Role of Endogenous Lymphoid-Resident Dendritic Cells in the Priming of NKT Cells and CD8+ T Cells to Dendritic Cell-Based Vaccines
por: Petersen, Troels R., et al.
Publicado: (2011)

Harnessing Nanoparticles for Immunomodulation and Vaccines
por: Gomes, Ariane C., et al.
Publicado: (2017)

Discovery of NKT cells and development of NKT cell-targeted anti-tumor immunotherapy
por: TANIGUCHI, Masaru, et al.
Publicado: (2015)

The Role of NKT Cells in Glioblastoma
por: Brettschneider, Emily E. S., et al.
Publicado: (2021)

NKT Cells in Sepsis
por: Leung, Briana, et al.
Publicado: (2010)

Natural Killer T (NKT) Cells and Periodontitis: Potential Regulatory Role of NKT10 Cells
por: Melgar-Rodríguez, Samanta, et al.
Publicado: (2021)

Role of NKT Cells during Viral Infection and the Development of NKT Cell-Based Nanovaccines
por: Khan, Masood Alam, et al.
Publicado: (2021)

Glycolipid‐peptide conjugate vaccines elicit CD8 (+) T‐cell responses and prevent breast cancer metastasis
por: Burn, Olivia K, et al.
Publicado: (2022)

NKT and NKT-like Cells in Autoimmune Neuroinflammatory Diseases—Multiple Sclerosis, Myasthenia Gravis and Guillain-Barre Syndrome
por: Zarobkiewicz, Michał K., et al.
Publicado: (2021)

MAIT cells activate dendritic cells to promote T(FH) cell differentiation and induce humoral immunity
por: Pankhurst, Theresa E., et al.
Publicado: (2023)

The role of NKT cells in gastrointestinal cancers
por: Burks, Julian, et al.
Publicado: (2021)

Role of NKT Cells in the Pathogenesis of NAFLD
por: Tajiri, Kazuto, et al.
Publicado: (2012)

Markers and makers of NKT17 cells
por: Liman, Nurcin, et al.
Publicado: (2023)

New ways to turn on NKT cells
por: Godfrey, Dale Ian, et al.
Publicado: (2011)

Harnessing T Follicular Helper Cell Responses for HIV Vaccine Development
por: Niessl, Julia, et al.
Publicado: (2018)

Vaccine Designs Utilizing Invariant NKT-Licensed Antigen-Presenting Cells Provide NKT or T Cell Help for B Cell Responses
por: Fujii, Shin-ichiro, et al.
Publicado: (2018)

NKT10 cells: a novel iNKT cell subset
por: Wingender, Gerhard, et al.
Publicado: (2015)

Recent advances in iNKT cell development
por: Hogquist, Kristin, et al.
Publicado: (2020)

Vaccine Vectors Harnessing the Power of Cytomegaloviruses
por: Ynga-Durand, Mario Alberto, et al.
Publicado: (2019)

Intracellular Bacterial Infection and Invariant NKT Cells
por: Emoto, Masashi, et al.
Publicado: (2009)

Immunoregulation of NKT Cells in Systemic Lupus Erythematosus
por: Chen, Junwei, et al.
Publicado: (2015)

Harnessing the Power of T Cells: The Promising Hope for a Universal Influenza Vaccine
por: Clemens, E. Bridie, et al.
Publicado: (2018)

NKT cell adjuvants in therapeutic vaccines against hematological cancers
por: Mattarollo, Stephen R., et al.
Publicado: (2013)

Regeneration of invariant natural killer T (iNKT) cells: application of iPSC technology for iNKT cell-targeted tumor immunotherapy
por: Aoki, Takahiro, et al.
Publicado: (2023)

The Current Landscape of NKT Cell Immunotherapy and the Hills Ahead
por: Nelson, Adam, et al.
Publicado: (2021)

The iNKT Cell–Macrophage Axis in Homeostasis and Disease
por: Cruz, Mariana S., et al.
Publicado: (2022)

The Transcriptional Repressor Gfi1 Plays a Critical Role in the Development of NKT1- and NKT2-Type iNKT Cells
por: Yasuoka, Toshiaki, et al.
Publicado: (2016)

From Lysosomal Storage Diseases to NKT Cell Activation and Back
por: Pereira, Cátia S., et al.
Publicado: (2017)

Harnessing donor unrestricted T-cells for new vaccines against tuberculosis
por: Joosten, Simone A., et al.
Publicado: (2019)

Trouble-making NKT cells
por: Van Epps, Heather L.
Publicado: (2005)

NKT cells depend on SAP
por: Van Epps, Heather L.
Publicado: (2005)

NKT cells reject islets
por: Van Epps, Heather L.
Publicado: (2005)

NKT cells get specialized
por: Van Epps, Heather L.
Publicado: (2005)

NKT Cells in Neurological Diseases
por: Cui, Yu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ag6344muufl6073759uoebrqmp